Crabtree, Thomas SJ

• British Journal of Diabetes Vol. 18 No. 1 (2018): January / February / March 2018 - Reviews
  Freestyle Libre: available on the NHS?
  Abstract  HTML  PDF
• British Journal of Diabetes Vol. 19 No. 2 (2019): DECEMBER 2019 - Original Research
  Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  The effect of dapagliflozin on alanine aminotransferase as a marker of liver inflammation: updated results from the ABCD dapagliflozin audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  Imeglimin, a novel, first in-class, blood glucose-lowering agent: a systematic review and meta-analysis of clinical evidence
  Abstract  PDF  Erratum  HTML
• British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Original Research
  Effects of canagliflozin are mostly observed at first follow-up, within 6 months of commencement: results for the ABCD canagliflozin audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Original Research
  Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD nationwide empagliflozin audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 19 No. 2 (2019): DECEMBER 2019 - Current Topics
  Diabetes technology
  Abstract  PDF  HTML